SCHEMBL23488239

SCHEMBL23488239

O=C(O)c1ccc(OC(=O)c2cccnc2)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 9/20 0.72
ATM Q13315 1/20 0.72
ALDH1A1 P00352 6/20 0.68
MAPT P10636 5/20 0.68
KDM4E B2RXH2 1/20 0.68
LMNA P02545 4/20 0.67
THRB P10828 1/20 0.67
CYP3A4 P08684 2/20 0.65
CYP1A2 P05177 2/20 0.63
CYP2C19 P33261 2/20 0.63
CYP2C9 P11712 1/20 0.63
TSHR P16473 1/20 0.63
APP P05067 1/20 0.62
GAA P10253 1/20 0.62
HCAR3 P49019 1/20 0.62
HCAR2 Q8TDS4 1/20 0.62
NFKB1 P19838 2/20 0.59
NFKB2 Q00653 2/20 0.59
RELA Q04206 2/20 0.59
NPC1 O15118 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21243070 0.92 KMT2A (0.84) KMT2AATMALDH1A1MAPTKDM4E
SCHEMBL502583 0.88 ALDH1A1 (0.78) KMT2AATMALDH1A1MAPTKDM4E
SCHEMBL28249586 0.86 KMT2A (0.61) KMT2AATMALDH1A1MAPTKDM4E
SCHEMBL23488236 0.86 KMT2A (0.70) KMT2AATMALDH1A1MAPTKDM4E
SCHEMBL21963567 0.84 KMT2A (0.78) KMT2AATMALDH1A1MAPTKDM4E
SCHEMBL31006272 0.84 KMT2A (1.00) KMT2AATMALDH1A1MAPTKDM4E
SCHEMBL29603721 0.84 KMT2A (1.00) KMT2AATMALDH1A1MAPTKDM4E
SCHEMBL5240749 0.84 KMT2A (1.00) KMT2AATMALDH1A1MAPTKDM4E
SCHEMBL9717156 0.84 KMT2A (0.72) KMT2AATMALDH1A1MAPTKDM4E
SCHEMBL10630518 0.82 KMT2A (0.68) KMT2AATMALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed
CN-106905534-B A kind of substep preparation method and application of high stable rare earth organic framework materials 浙江大学 2019-08-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 KMT2A 4555/4885ATM 4567/4885ALDH1A1 1627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.